Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03756714
Other study ID # TFCCFF.PMCF.2017.12
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 28, 2018
Est. completion date September 29, 2021

Study information

Verified date October 2021
Source Smith & Nephew, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Assess safety and performance post-market of the TFCC FastFix in the wrist.


Recruitment information / eligibility

Status Completed
Enrollment 88
Est. completion date September 29, 2021
Est. primary completion date September 29, 2021
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients who have undergone TFCC repair using the TFCC FastFix Device - Patients aged 18 years and older - Patients that are > 12 months post-operative. Exclusion Criteria: - Subjects who are < 12 months post-operative - Subject is entered in another investigational drug, biologic, or device study or has been treated with an investigational product within 12 months post-operative.

Study Design


Related Conditions & MeSH terms

  • Suture Retention Device to Facilitate Triangular Fibrocartilage Complex (TFCC) Repair

Locations

Country Name City State
United States Miami Orthopedics & Sport Medicine Institute Miami Florida

Sponsors (1)

Lead Sponsor Collaborator
Smith & Nephew, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate (%) of clinical success of six months post-operative. Clinical success is defined as wrists without signs of device failure and/or re-intervention after assessment by surgeon 6 months